What is TRexit?

/
Screen Shot 2020-01-16 at 1.08.21 pm.png

Australia has been leading the world in its practice of performing prostate biopsy via the skin (Transperineal Biopsy) instead of via the rectum (Transrectal). Movember’s Prostate Cancer Outcomes Registry shows that in Victoria, the majority of prostate biopsies are now performed via the skin. In 2013, it was only 5%.

There are 2 major advantages to patients. Our research has shown that the sepsis rate when performing prostate biopsy via the skin is zero or near zero. This is in contrast to the increasing rates of sepsis from transrectal biopsy we are seeing worldwide.

Secondly, no antibiotics are needed for Transperineal biopsy. This makes the wider community safer, as it avoids the promotion of multi-resistant bacteria (superbugs).

The world is taking notice, with the switch from Transrectal to Transperineal prostate biopsy - TRexit - gaining momentum. Here’s an article I wrote with leaders in this field from around the world to raise awareness and advocate for patient safety: https://go.nature.com/3cmimWm

A safer way to biopsy the prostate

/
A safer way to biopsy the prostate

Dr Grummet was invited to write this article as a guest blog on Adelaide Urologist Dr Nicholas Brook’s website in February 2014.

What’s wrong with the current standard method of prostate biopsy?
What is transperineal biopsy, and why is it safer?
Are there any downsides to the transperineal approach?
Is it as good as TRUS at cancer detection?
What other advantage might TP biopsy provide?

Read More

Multiparametric MRI – Changing the face of prostate cancer diagnosis

/
Multiparametric MRI – Changing the face of prostate cancer diagnosis

Dr Grummet wrote this article published in the June 2014 edition of Medical Observer.

At last. Through the dark clouds of controversy that have cast shadows over the diagnosis of prostate cancer for so many years, a ray of light is just starting to shine through. That light’s somewhat longwinded name is multiparametric MRI.

Read More